Chromatin Conformation of Integrated Moloney Leukemia Virus DNA Sequences in Tissues of BALB/Mo Mice and in Virus-Infected Cell Lines

1980 ◽  
Vol 34 (2) ◽  
pp. 373-382 ◽  
Author(s):  
Michael Breindl ◽  
Lee Bacheler ◽  
Hung Fan ◽  
Rudolf Jaenisch
Virology ◽  
1979 ◽  
Vol 97 (2) ◽  
pp. 231-240 ◽  
Author(s):  
Thomas L. Sacks ◽  
Elizabeth J. Hershey ◽  
John R. Stephenson

1994 ◽  
Vol 86 (1) ◽  
pp. 33-40 ◽  
Author(s):  
C. Dees ◽  
V.L. Godfrey ◽  
J.S. Foster ◽  
R.D. Schultz ◽  
C.C. Travis

1991 ◽  
Vol 27 (1-3) ◽  
pp. 207-213 ◽  
Author(s):  
J.J. Letesson ◽  
A. Van den Broecke ◽  
Y. Marbaix-Cleuter ◽  
M. Delcommenne ◽  
A. Mager ◽  
...  

Pathology ◽  
1988 ◽  
Vol 20 (2) ◽  
pp. 105-108 ◽  
Author(s):  
Daniela Zauli ◽  
Cristina Crespi ◽  
Monica Musiani ◽  
Marialuisa Zerbini

Viruses ◽  
2019 ◽  
Vol 11 (7) ◽  
pp. 651 ◽  
Author(s):  
Maritza Puray-Chavez ◽  
Mahmoud Farghali ◽  
Vincent Yapo ◽  
Andrew Huber ◽  
Dandan Liu ◽  
...  

Moloney leukemia virus 10 (MOV10) is an RNA helicase that has been shown to affect the replication of several viruses. The effect of MOV10 on Hepatitis B virus (HBV) infection is not known and its role on the replication of this virus is poorly understood. We investigated the effect of MOV10 down-regulation and MOV10 over-expression on HBV in a variety of cell lines, as well as in an infection system using a replication competent virus. We report that MOV10 down-regulation, using siRNA, shRNA, and CRISPR/Cas9 gene editing technology, resulted in increased levels of HBV DNA, HBV pre-genomic RNA, and HBV core protein. In contrast, MOV10 over-expression reduced HBV DNA, HBV pre-genomic RNA, and HBV core protein. These effects were consistent in all tested cell lines, providing strong evidence for the involvement of MOV10 in the HBV life cycle. We demonstrated that MOV10 does not interact with HBV-core. However, MOV10 binds HBV pgRNA and this interaction does not affect HBV pgRNA decay rate. We conclude that the restriction of HBV by MOV10 is mediated through effects at the level of viral RNA.


1989 ◽  
Vol 9 (11) ◽  
pp. 4670-4676 ◽  
Author(s):  
T Tsukiyama ◽  
O Niwa ◽  
K Yokoro

Sequence-specific DNA-binding proteins that bind to the long terminal repeat (LTR) of Moloney leukemia virus in undifferentiated and differentiated mouse embryonal carcinoma (EC) cells were identified by gel retardation assay. The proteins that bind to the CCAAT box were present in both undifferentiated and differentiated EC cells. The amounts and the number of species of the proteins that bind to the enhancer and the GC-rich region were far lower in undifferentiated EC cells than in the differentiated counterparts. These proteins were supposed to be transcriptional activators. Proteins that bind upstream of the enhancer, namely, the -352 to -346 region and the -407 to -404 region, were identified. These proteins were designated the embryonic LTR-binding protein (ELP) and the LTR-binding protein, respectively. The ELP was present only in undifferentiated EC cell lines. The LTR-binding protein was detected in all cell lines tested. The mechanism of suppression of the LTR was investigated by the chloramphenicol acetyltransferase assay. The enhancer and the GC-rich region of the LTR functioned poorly in undifferentiated cells. When eight copies of ELP-binding sequences were inserted upstream of the enhancer region, expression of the chloramphenicol acetyltransferase gene was reduced about threefold in ECA2 cells. From these data, we concluded that two mechanisms, the shortage of activator proteins and the presence of a negative regulatory protein (ELP), are involved in the suppression of the LTR in undifferentiated EC cells.


Sign in / Sign up

Export Citation Format

Share Document